Pubdate: Mon, 02 Apr 2001 Source: Kingsport Times-News (TN) Copyright: 2001 Kingsport Publishing Corporation Contact: http://www.mapinc.org/media/1437 Website: http://www.timesnews.net/index.cgi Author: Matthew Lane Note: Will not publish letters in print editions from online users who do not reside in print circulation area, unless they are former residents or have some current connection to Southwest Virginia and Northeast Tennessee. VIRGINIA WORKING ON WAYS TO CURB PRESCRIPTION DRUG ABUSE BRISTOL, Va. - Virginia Attorney General Mark Earley wants to make OxyContin available to the patients who need it and make sure the prescription drug does not end up in the wrong hands. Earley spoke on the issue during a recent visit to Bristol, Va. Earley was in the Twin Cities last week stumping for Bristol Virginia Police Sgt. Kevin Corbett, who is running for sheriff of Bristol. Earley discussed a summit that was held March 1 and attended by attorneys general from states affected by OxyContin abuse, along with state police and law enforcement officials. "We met with the producer/manufacturer of OxyContin, Purdue Pharma, which is located in Connecticut, and the purpose of that meeting was to focus attention on this problem and to begin finding solutions to it both from a law enforcement angle and as well as getting the drug maker to help us with that," Earley said. "Several things came out as a result of that meeting." Earley said Virginia is forming a statewide task force to focus on prescription drug abuse, specifically OxyContin. "It's something I've talked to about with Sgt. Corbett if he becomes sheriff, in participating with us in that effort," Earley said. "We'll be announcing the members of that task force next week." In addition, Earley said he will be heading a national task force of attorneys general, and cooperation was agreed to by Purdue Pharma. "They agreed to provide $100,000 for a research project at one of our research institutions here in Virginia in order to fund a study of a prescription monitoring control system," Earley said. "This would be a system whereby if you are a pharmacist and I come to you to fill a prescription on OxyContin, you can plug my name into a computer, and it will show whether I have been to another pharmacy or another pharmacist to have a similar prescription filled - and if so, when. "Because part of the problem we have with prescription drug abuse is people shopping for doctors in different states or regions and shopping around at different pharmacies." Purdue Pharma has also agreed to work with Virginia in developing an educational program for health care professionals, Earley said. "To talk about the nature of this drug and how to keep it out of the hands of those who abuse it," Earley said. "This drug is a very, very good and potent drug when used appropriately - one of the new wonder drugs that we're able to have now because of advancement in pharmacological studies." OxyContin is used to treat severe cancer pain and has a sustained time-release effect. "When used appropriately for people who have black lung disease or significant pain with cancer, it's great," Earley said. "When abused it's deadly and highly addictive. "Our goal is to continue to make it available for patients but make sure it doesn't end up in the wrong hands."